Selected research
Industry Research
Cell Activity Assay Service Industry Research Report 2026
Market perspective
The global Cell Activity Assay Service market was valued at US$ million in 2025 and is projected to reach US$ million by 2032, implying a CAGR of % over 2026–2032.
North America: the Cell Activity Assay Service market is projected to increase from US$ million in 2026 to US$ million by 2032, reflecting a CAGR of % over 2026–2032. Europe: the Cell Activity Assay Service market is projected to rise from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026–2032. Asia Pacific: the Cell Activity Assay Service market is expected to grow from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026–2032. Leading global service providers of Cell Activity Assay Service include Promab Biotechnologies, IBR Inc, Multispan, Promega, Domainex, BioAgilytix, Charles River Laboratories, MD Biosciences and Creative Bioarray, among others; in 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
Read the full market overview
This report quantifies the global Cell Activity Assay Service market in terms of revenue (US$ million) and, where applicable, service volume (Unit), using 2024 as the base year and providing annual historical and forecast data for 2021–2032.
It standardizes definitions of service Types and end-use Applications, harmonizes provider attribution, and delivers comparable time series by company, Type, Application, and region or country, including indicative price bands (US$/Unit) and concentration ratios (CR5/CR10). Outputs are intended to support service design, budgeting, capacity planning, and benchmarking for providers, platforms, channel partners, and investors; the report also reviews technology shifts and notable service innovations relevant to Cell Activity Assay Service.
Key Companies & Market Share Insights
This section profiles leading service providers with 2021–2025 results and a 2026–2032 outlook—covering revenue, market share, price bands, service portfolio and client mix, regional and channel mix, and key developments (M&A, network expansion, certifications). It also provides global revenue, average price, and—where applicable—volume metrics by provider, and calculates CR5/CR10 and rank changes to support comparative benchmarking.
Cell Activity Assay Service Market by Company
Promab Biotechnologies
IBR Inc
Multispan
Promega
Domainex
BioAgilytix
Charles River Laboratories
MD Biosciences
Creative Bioarray
STEMCELL Technologies
Lonza Bioscience
Merck KGaA
Thermo Fisher Scientific
MarinBio
Visikol
Malvern Panalytical
SGS
Innoprot
Vela Labs GmbH
Hanugen Theraputics
Cell Activity Assay Service Segment by Type
ATP Content Determination Method
Fluorescent Staining Method
Colorimetric Method
Other
Cell Activity Assay Service Segment by Application
Biopharmaceutical and Biotechnology Companies
Research Institutes
Cell Activity Assay Service Segment by Region
North America
United States
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Spain
Russia
Netherlands
Nordic Countries
Asia-Pacific
China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America
Brazil
Argentina
Chile
Middle East & Africa
Saudi Arabia
Israel
United Arab Emirates
Turkey
Iran
Egypt
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Cell Activity Assay Service market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of Cell Activity Assay Service and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Cell Activity Assay Service.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Provides the analysis of various market segments product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 4: Provides the analysis of various market segments application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 5: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 6: Detailed analysis of Cell Activity Assay Service companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 7, 8, 9, 10, 11: North America, Europe, Asia Pacific, South America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 12: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.
Chapter 13: The main points and conclusions of the report.
More report detail
Tables and figures
Scope & coverage.
Types
- ATP Content Determination Method
- Fluorescent Staining Method
- Colorimetric Method
- Other
Applications
- Biopharmaceutical and Biotechnology Companies
- Research Institutes
Companies covered
- Promab Biotechnologies
- IBR Inc
- Multispan
- Promega
- Domainex
- BioAgilytix
- Charles River Laboratories
- MD Biosciences
- Creative Bioarray
- STEMCELL Technologies
- Lonza Bioscience
- Merck KGaA
- Thermo Fisher Scientific
- MarinBio
- Visikol
- Malvern Panalytical
- SGS
- Innoprot
- Vela Labs GmbH
- Hanugen Theraputics
Inside the report.
1 Preface
- 1.1 Scope of Report
- 1.2 Reasons for Doing This Study
- 1.3 Research Methodology
- 1.4 Research Process
- 1.5 Data Source
- 1.5.1 Secondary Sources
- 1.5.2 Primary Sources
2 Market Overview
- 2.1 Product Definition
- 2.2 Cell Activity Assay Service by Type
- 2.2.1 Market Value Comparison by Type (2021 VS 2025 VS 2032)
- 2.2.2 ATP Content Determination Method
- 2.2.3 Fluorescent Staining Method
- 2.2.4 Colorimetric Method
- 2.2.5 Other
- 2.3 Cell Activity Assay Service by Application
- 2.3.1 Market Value Comparison by Application (2021 VS 2025 VS 2032)
- 2.3.2 Biopharmaceutical and Biotechnology Companies
- 2.3.3 Research Institutes
- 2.4 Assumptions and Limitations
3 Cell Activity Assay Service Breakdown Data by Type
- 3.1 Global Cell Activity Assay Service Historic Market Size by Type (2021-2026)
- 3.2 Global Cell Activity Assay Service Forecasted Market Size by Type (2027-2032)
4 Cell Activity Assay Service Breakdown Data by Application
- 4.1 Global Cell Activity Assay Service Historic Market Size by Application (2021-2026)
- 4.2 Global Cell Activity Assay Service Forecasted Market Size by Application (2027-2032)
5 Global Growth Trends
- 5.1 Global Cell Activity Assay Service Market Perspective (2021-2032)
- 5.2 Global Cell Activity Assay Service Growth Trends by Region
- 5.2.1 Global Cell Activity Assay Service Market Size by Region: 2021 VS 2025 VS 2032
- 5.2.2 Cell Activity Assay Service Historic Market Size by Region (2021-2026)
- 5.2.3 Cell Activity Assay Service Forecasted Market Size by Region (2027-2032)
- 5.3 Cell Activity Assay Service Market Dynamics
- 5.3.1 Cell Activity Assay Service Industry Trends
- 5.3.2 Cell Activity Assay Service Market Drivers
- 5.3.3 Cell Activity Assay Service Market Challenges
- 5.3.4 Cell Activity Assay Service Market Restraints
6 Market Competitive Landscape by Players
- 6.1 Global Top Cell Activity Assay Service Players by Revenue
- 6.1.1 Global Top Cell Activity Assay Service Players by Revenue (2021-2026)
- 6.1.2 Global Cell Activity Assay Service Revenue Market Share by Players (2021-2026)
- 6.2 Global Cell Activity Assay Service Industry Players Ranking, 2023 VS 2024 VS 2025
- 6.3 Global Key Players of Cell Activity Assay Service Head Office and Area Served
- 6.4 Global Cell Activity Assay Service Players, Product Type & Application
- 6.5 Global Cell Activity Assay Service Manufacturers Established Date
- 6.6 Global Cell Activity Assay Service Market CR5 and HHI
- 6.7 Global Players Mergers & Acquisition
7 North America
- 7.1 North America Cell Activity Assay Service Market Size (2021-2032)
- 7.2 North America Cell Activity Assay Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 7.3 North America Cell Activity Assay Service Market Size by Country (2021-2026)
- 7.4 North America Cell Activity Assay Service Market Size by Country (2027-2032)
- 7.5 United States
- 7.5 United States
- 7.6 Canada
- 7.7 Mexico
8 Europe
- 8.1 Europe Cell Activity Assay Service Market Size (2021-2032)
- 8.2 Europe Cell Activity Assay Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 8.3 Europe Cell Activity Assay Service Market Size by Country (2021-2026)
- 8.4 Europe Cell Activity Assay Service Market Size by Country (2027-2032)
- 8.5 Germany
- 8.6 France
- 8.7 U.K.
- 8.8 Italy
- 8.9 Spain
- 8.10 Russia
- 8.11 Netherlands
- 8.12 Nordic Countries
9 Asia-Pacific
- 9.1 Asia-Pacific Cell Activity Assay Service Market Size (2021-2032)
- 9.2 Asia-Pacific Cell Activity Assay Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 9.3 Asia-Pacific Cell Activity Assay Service Market Size by Country (2021-2026)
- 9.4 Asia-Pacific Cell Activity Assay Service Market Size by Country (2027-2032)
- 9.5 China
- 9.6 Japan
- 9.7 South Korea
- 9.8 India
- 9.9 Australia
- 9.10 China Taiwan
- 9.11 Southeast Asia
10 South America
- 10.1 South America Cell Activity Assay Service Market Size (2021-2032)
- 10.2 South America Cell Activity Assay Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 10.3 South America Cell Activity Assay Service Market Size by Country (2021-2026)
- 10.4 South America Cell Activity Assay Service Market Size by Country (2027-2032)
- 10.5 Brazil
- 10.6 Argentina
- 10.7 Chile
- 10.8 Colombia
- 10.9 Peru
11 Middle East & Africa
- 11.1 Middle East & Africa Cell Activity Assay Service Market Size (2021-2032)
- 11.2 Middle East & Africa Cell Activity Assay Service Market Growth Rate by Country: 2021 VS 2025 VS 2032
- 11.3 Middle East & Africa Cell Activity Assay Service Market Size by Country (2021-2026)
- 11.4 Middle East & Africa Cell Activity Assay Service Market Size by Country (2027-2032)
- 11.5 Saudi Arabia
- 11.6 Israel
- 11.7 United Arab Emirates
- 11.8 Turkey
- 11.9 Iran
- 11.10 Egypt
12 Players Profiled
- 12.1 Promab Biotechnologies
- 12.1.1 Promab Biotechnologies Company Information
- 12.1.2 Promab Biotechnologies Business Overview
- 12.1.3 Promab Biotechnologies Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.1.4 Promab Biotechnologies Cell Activity Assay Service Product Portfolio
- 12.1.5 Promab Biotechnologies Recent Developments
- 12.2 IBR Inc
- 12.2.1 IBR Inc Company Information
- 12.2.2 IBR Inc Business Overview
- 12.2.3 IBR Inc Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.2.4 IBR Inc Cell Activity Assay Service Product Portfolio
- 12.2.5 IBR Inc Recent Developments
- 12.3 Multispan
- 12.3.1 Multispan Company Information
- 12.3.2 Multispan Business Overview
- 12.3.3 Multispan Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.3.4 Multispan Cell Activity Assay Service Product Portfolio
- 12.3.5 Multispan Recent Developments
- 12.4 Promega
- 12.4.1 Promega Company Information
- 12.4.2 Promega Business Overview
- 12.4.3 Promega Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.4.4 Promega Cell Activity Assay Service Product Portfolio
- 12.4.5 Promega Recent Developments
- 12.5 Domainex
- 12.5.1 Domainex Company Information
- 12.5.2 Domainex Business Overview
- 12.5.3 Domainex Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.5.4 Domainex Cell Activity Assay Service Product Portfolio
- 12.5.5 Domainex Recent Developments
- 12.6 BioAgilytix
- 12.6.1 BioAgilytix Company Information
- 12.6.2 BioAgilytix Business Overview
- 12.6.3 BioAgilytix Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.6.4 BioAgilytix Cell Activity Assay Service Product Portfolio
- 12.6.5 BioAgilytix Recent Developments
- 12.7 Charles River Laboratories
- 12.7.1 Charles River Laboratories Company Information
- 12.7.2 Charles River Laboratories Business Overview
- 12.7.3 Charles River Laboratories Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.7.4 Charles River Laboratories Cell Activity Assay Service Product Portfolio
- 12.7.5 Charles River Laboratories Recent Developments
- 12.8 MD Biosciences
- 12.8.1 MD Biosciences Company Information
- 12.8.2 MD Biosciences Business Overview
- 12.8.3 MD Biosciences Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.8.4 MD Biosciences Cell Activity Assay Service Product Portfolio
- 12.8.5 MD Biosciences Recent Developments
- 12.9 Creative Bioarray
- 12.9.1 Creative Bioarray Company Information
- 12.9.2 Creative Bioarray Business Overview
- 12.9.3 Creative Bioarray Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.9.4 Creative Bioarray Cell Activity Assay Service Product Portfolio
- 12.9.5 Creative Bioarray Recent Developments
- 12.10 STEMCELL Technologies
- 12.10.1 STEMCELL Technologies Company Information
- 12.10.2 STEMCELL Technologies Business Overview
- 12.10.3 STEMCELL Technologies Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.10.4 STEMCELL Technologies Cell Activity Assay Service Product Portfolio
- 12.10.5 STEMCELL Technologies Recent Developments
- 12.11 Lonza Bioscience
- 12.11.1 Lonza Bioscience Company Information
- 12.11.2 Lonza Bioscience Business Overview
- 12.11.3 Lonza Bioscience Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.11.4 Lonza Bioscience Cell Activity Assay Service Product Portfolio
- 12.11.5 Lonza Bioscience Recent Developments
- 12.12 Merck KGaA
- 12.12.1 Merck KGaA Company Information
- 12.12.2 Merck KGaA Business Overview
- 12.12.3 Merck KGaA Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.12.4 Merck KGaA Cell Activity Assay Service Product Portfolio
- 12.12.5 Merck KGaA Recent Developments
- 12.13 Thermo Fisher Scientific
- 12.13.1 Thermo Fisher Scientific Company Information
- 12.13.2 Thermo Fisher Scientific Business Overview
- 12.13.3 Thermo Fisher Scientific Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.13.4 Thermo Fisher Scientific Cell Activity Assay Service Product Portfolio
- 12.13.5 Thermo Fisher Scientific Recent Developments
- 12.14 MarinBio
- 12.14.1 MarinBio Company Information
- 12.14.2 MarinBio Business Overview
- 12.14.3 MarinBio Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.14.4 MarinBio Cell Activity Assay Service Product Portfolio
- 12.14.5 MarinBio Recent Developments
- 12.15 Visikol
- 12.15.1 Visikol Company Information
- 12.15.2 Visikol Business Overview
- 12.15.3 Visikol Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.15.4 Visikol Cell Activity Assay Service Product Portfolio
- 12.15.5 Visikol Recent Developments
- 12.16 Malvern Panalytical
- 12.16.1 Malvern Panalytical Company Information
- 12.16.2 Malvern Panalytical Business Overview
- 12.16.3 Malvern Panalytical Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.16.4 Malvern Panalytical Cell Activity Assay Service Product Portfolio
- 12.16.5 Malvern Panalytical Recent Developments
- 12.17 SGS
- 12.17.1 SGS Company Information
- 12.17.2 SGS Business Overview
- 12.17.3 SGS Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.17.4 SGS Cell Activity Assay Service Product Portfolio
- 12.17.5 SGS Recent Developments
- 12.18 Innoprot
- 12.18.1 Innoprot Company Information
- 12.18.2 Innoprot Business Overview
- 12.18.3 Innoprot Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.18.4 Innoprot Cell Activity Assay Service Product Portfolio
- 12.18.5 Innoprot Recent Developments
- 12.19 Vela Labs GmbH
- 12.19.1 Vela Labs GmbH Company Information
- 12.19.2 Vela Labs GmbH Business Overview
- 12.19.3 Vela Labs GmbH Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.19.4 Vela Labs GmbH Cell Activity Assay Service Product Portfolio
- 12.19.5 Vela Labs GmbH Recent Developments
- 12.20 Hanugen Theraputics
- 12.20.1 Hanugen Theraputics Company Information
- 12.20.2 Hanugen Theraputics Business Overview
- 12.20.3 Hanugen Theraputics Revenue in Cell Activity Assay Service Business (2021-2026)
- 12.20.4 Hanugen Theraputics Cell Activity Assay Service Product Portfolio
- 12.20.5 Hanugen Theraputics Recent Developments
13 Report Conclusion
14 Disclaimer
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst